[1]
|
Tosi, G., Pederzoli, F., Belletti, D., Vandelli, M.A., Forni, F., Duskey, J.T. and Ruozi, B. (2019) Nanomedicine in Alzheimer’s Disease: Amyloid Beta Targeting Strategy. In: Sharma, A. and Sharma, S., Eds., Progress in Brain Research, Vol. 245, Elsevier B.V., Berlin, 57-88. https://doi.org/10.1016/bs.pbr.2019.03.001
|
[2]
|
Henstridge, C.M., Hyman, B.T. and Spires-Jones, T.L. (2019) Beyond the Neuron-Cellular Interactions Early in Alzheimer Disease Pathogenesis. Nature Reviews Neuroscience, 176, 139-148.
|
[3]
|
Liu, P.P., Xie, Y., Meng, X.Y. and Kang, J.S. (2019) History and Progress of Hypotheses and Clinical Trials for Alzheimer’s Disease. Signal Transduction and Targeted Therapy, 4, Article No. 29. https://doi.org/10.1038/s41392-019-0063-8
|
[4]
|
Deture, M.A. and Dickson, D.W. (2019) The Neuropathological Diagnosis of Alzheimer’s Disease. Molecular Neurodegeneration, 14, Article No. 32.
https://doi.org/10.1186/s13024-019-0333-5
|
[5]
|
Fabiani, C., Antollini, S.S., Guido, M.E., Eckert, G.P. and Stephan, A. (2019) Alzheimer’s Disease as a Membrane Disorder: Spatial Cross-Talk among Beta-Amyloid Peptides, Nicotinic Acetylcholine Receptors and Lipid Rafts. Frontiers in Cellular Neuroscience, 13, Article No. 309. https://doi.org/10.3389/fncel.2019.00309
|
[6]
|
Arbor, S.C., Lafontaine, M. and Cumbay, M. (2016) Amyloid-Beta Alzheimer Targets—Protein Processing, Lipid Rafts, and Amyloid-Beta Pores. Yale Journal of Biology and Medicine, 89, 5-21.
|
[7]
|
Qian, X., Hamad, B. and Dias-Lalcaca, G. (2015) The Alzheimer Disease Market. Nature Reviews Drug Discovery, 14, 675-676. https://doi.org/10.1038/nrd4749
|
[8]
|
Chen, X.Q. and Mobley, W.C. (2019) Alzheimer Disease Pathogenesis: Insights from Molecular and Cellular Biology Studies of Oligomeric Aβ and Tau Species. Frontiers in Neuroscience, 13, 659. https://doi.org/10.3389/fnins.2019.00659
|
[9]
|
Tofoleanu, F. and Buchete, N.-V. (2012) Molecular Interactions of Alzheimer’s Aβ Protofilaments with Lipid Membranes. Journal of Molecular Biology, 421, 572-586.
https://doi.org/10.1016/j.jmb.2011.12.063
|
[10]
|
Tofoleanu, F., Brooks, B.R. and Buchete, N.-V. (2015) Modulation of Alzheimer’s Aβ Protofilament-Membrane Interactions by Lipid Headgroups. ACS Chemical Neuroscience, 6, 446-455. https://doi.org/10.1021/cn500277f
|
[11]
|
Kaminsky, Y.G., Marlatt, M.W., Smith, M.A. and Kosenko, E.A. (2010) Subcellular and Metabolic Examination of Amyloid-β Peptides in Alzheimer Disease Pathogenesis: Evidence for Aβ25-35. Experimental Neurology, 221, 26-37.
https://doi.org/10.1016/j.expneurol.2009.09.005
|
[12]
|
Findley, C.A., Bartke, A., Hascup, K.N. and Hascup, E.R. (2019) Amyloid Beta-Related Alterations to Glutamate Signaling Dynamics During Alzheimer’s Disease Progression. ASN Neuro, 11, 1-20. https://doi.org/10.1177/1759091419855541
|
[13]
|
Cline, E.N., Bicca, M.A., Viola, K.L. and Klein, W.L. (2018) The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade. Journal of Alzheimer’s Disease, 64, S567-S610. https://doi.org/10.3233/JAD-179941
|
[14]
|
Tofoleanu, F. and Buchete, N.-V. (2012) Alzheimer Aβ Peptide Interactions with Lipid Membranes. Prion, 6, 339-345. https://doi.org/10.4161/pri.21022
|
[15]
|
Wen, J., Fang, F., Guo, S.H., Zhang, Y., Peng, X.L., Sun, W.M., Wei, X.R., He, J.S. and Hung, T. (2018) Amyloid β-Derived Diffusible Ligands (ADDLs) Induce Abnormal Autophagy Associated with Aβ Aggregation Degree. Journal of Molecular Neuroscience, 64, 162-174. https://doi.org/10.1007/s12031-017-1015-9
|
[16]
|
Liu, X., Teng, Z., Cui, C., Wang, R., Liu, M. and Zhang, Y. (2014) Amyloid Beta-Derived Diffusible Ligands (ADDLs) Induce Abnormal Expression of Insulin Receptors in Rat Hippocampal Neurons. Journal of Molecular Neuroscience, 52, 124-130.
https://doi.org/10.1007/s12031-013-0216-0
|
[17]
|
Catalano, S., Dodson, E., Henze, D., Joyce, J., Krafft, G. and Kinney, G. (2006) The Role of Amyloid-Beta Derived Diffusible Ligands (ADDLs) in Alzheimers Disease. Current Topics in Medicinal Chemistry, 6, 597-608.
https://doi.org/10.2174/156802606776743066
|
[18]
|
Liu, Z., Li, T., Li, P., Wei, N., Zhao, Z., Liang, H., Ji, X., Chen, W., Xue, M. and Wei, J. (2015) The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer’s Disease. Oxidative Medicine and Cellular Longevity, 2015, Article ID: 352723. https://doi.org/10.1155/2015/352723
|
[19]
|
Reed, S.G., Coler, R.N., Dalemans, W., Tan, E.V., Dela Cruz, E.C., Basaraba, et al. (2009) Protection of Synapses against Alzheimer’s-Linked Toxins: Insulin Signaling Prevents the Pathogenic Binding of Aβ Oligomers. Proceedings of the National Academy of Sciences of the United States of America, 106, 7678.
https://doi.org/10.1073/pnas.0902058106
|
[20]
|
Hana, W. and Lic, C. (2010) Linking Type 2 Diabetes and Alzheimer’s Disease. Proceedings of the National Academy of Sciences of the United States of America, 107, 6557-6558. https://doi.org/10.1073/pnas.1002555107
|
[21]
|
Giammalva, G.R., Iacopino, D.G., Graziano, F., Gulì, C., Pino, M.A. and Maugeri, R. (2018) Review of the Neurological Benefits of Phytocannabinoids. Surgical Neurology International, 9, Article No. 91. https://doi.org/10.4103/sni.sni_223_18
|
[22]
|
Meissner, H. and Cascella, M. (2020) Cannabidiol (CBD). StatPearls, Treasure Island. https://www.ncbi.nlm.nih.gov/books/NBK556048
|
[23]
|
Iuvone, T., Esposito, G., De Filippis, D., Scuderi, C. and Steardo, L. (2009) Cannabidiol: A Promising Drug for Neurodegenerative Disorders? CNS Neuroscience and Therapeutics, 15, 65-75. https://doi.org/10.1111/j.1755-5949.2008.00065.x
|
[24]
|
Pereira, S.R., Hackett, B., O’Driscoll, D.N., Sun, M.C. and Downer, E.J. (2021) Cannabidiol Modulation of Oxidative Stress and Signalling. Neuronal Signaling, 5, NS20200080. https://doi.org/10.1042/NS20200080
|
[25]
|
Campbell, V.A. and Gowran, A. (2007) Alzheimer’s Disease, Taking the Edge off with Cannabinoids? British Journal of Pharmacology, 152, 655-662.
https://doi.org/10.1038/sj.bjp.0707446
|
[26]
|
Iuvone, T., Esposito, G., Esposito, R., Santamaria, R., Di Rosa, M. and Izzo, A.A. (2004) Neuroprotective Effect of Cannabidiol, a Non-Psychoactive Component from Cannabis Sativa, on β-Amyloid-Induced Toxicity in PC12 Cells. Journal of Neurochemistry, 89, 134-141. https://doi.org/10.1111/j.1471-4159.2003.02327.x
|
[27]
|
Janefjord, E., Maag, J.L.V., Harvey, B.S. and Smid, S.D. (2014) Cannabinoid Effects on β Amyloid Fibril and Aggregate Formation, Neuronal and Microglial-Activated Neurotoxicity in Vitro. Cellular and Molecular Neurobiology, 34, 31-42.
https://doi.org/10.1007/s10571-013-9984-x
|
[28]
|
Hughes, B. and Herron, C.E. (2019) Cannabidiol Reverses Deficits in Hippocampal LTP in a Model of Alzheimer’s Disease. Neurochemical Research, 44, 703-713.
https://doi.org/10.1007/s11064-018-2513-z
|
[29]
|
Watt, G., Shang, K., Zieba, J., Olaya, J., Li, H., Garner, B. and Karl, T. (2020) Chronic Treatment with 50 mg/kg Cannabidiol Improves Cognition and Moderately Reduces Aβ42 Levels in 12-Month-Old Male AβPPswe/PS1ΔE9 Transgenic Mice. Journal of Alzheimer’s Disease, 61, 1-14. https://doi.org/10.3233/JAD-191242
|
[30]
|
Uddin, Md.S., Mamun, A., Sumsuzzman, D.Md., Ashraf, G.M., Perveen, A., Bungau, S.G., et al. (2020) Emerging Promise of Cannabinoids for the Management of Pain and Associated Neuropathological Alterations in Alzheimer’s Disease. Frontiers in Pharmacology, 11, 1097. https://doi.org/10.3389/fphar.2020.01097
|
[31]
|
Harper, J.D., Wong, S.S., Lieber, C.M. and Lansbury, P.T. (1997) Observation of Metastable Aβ Amyloid Protofibrils by Atomic Force Microscopy. Chemistry and Biology, 4, 119-125. https://doi.org/10.1016/S1074-5521(97)90255-6
|
[32]
|
Goldsbury, C., Kistler, J., Aebi, U., Arvinte, T. and Cooper, G.J.S. (1999) Watching Amyloid Fibrils Grow by Time-Lapse Atomic Force Microscopy. Journal of Molecular Biology, 285, 33-39. https://doi.org/10.1006/jmbi.1998.2299
|
[33]
|
Kowalewski, T. and Holtzman, D.M. (1999) In Situ Atomic Force Microscopy Study of Alzheimer’s β-Amyloid Peptide on Different Substrates: New Insights into Mechanism of β-Sheet Formation. Proceedings of the National Academy of Sciences of the United States of America, 96, 3688-3693. https://doi.org/10.1073/pnas.96.7.3688
|
[34]
|
Fukuma, T., Mostaert, A.S., Serpell, L.C. and Jarvis, S.P. (2008) Revealing Molecular-Level Surface Structure of Amyloid Fibrils in Liquid by Means of Frequency Modulation Atomic Force Microscopy. Nanotechnology, 19, Article ID: 384010.
https://doi.org/10.1088/0957-4484/19/38/384010
|
[35]
|
Adamcik, J., Jung, J.M., Flakowski, J., De Los Rios, P., Dietler, G. and Mezzenga, R. (2010) Understanding Amyloid Aggregation by Statistical Analysis of Atomic Force Microscopy Images. Nature Nanotechnology, 5, 423-428.
https://doi.org/10.1038/nnano.2010.59
|
[36]
|
Mastrangelo, I.A., Ahmed, M., Sato, T., Liu, W., Wang, C., Hough, P. and Smith, S.O. (2006) High-Resolution Atomic Force Microscopy of Soluble Aβ42 Oligomers. Journal of Molecular Biology, 358, 106-119.
https://doi.org/10.1016/j.jmb.2006.01.042
|
[37]
|
Economou, N.J., Giammona, M.J., Do, T.D., Zheng, X., Teplow, D.B., Buratto, S.K. and Bowers, M.T. (2016) Amyloid β-Protein Assembly and Alzheimer’s Disease: Dodecamers of Aβ42, but Not of Aβ40, Seed Fibril Formation. Journal of the American Chemical Society, 138, 1772-1775. https://doi.org/10.1021/jacs.5b11913
|
[38]
|
Cherny, I. and Gazit, E. (2008) Amyloids: Not Only Pathological Agents but Also Ordered Nanomaterials. Angewandte Chemie—International Edition, 47, 4062-4069.
https://doi.org/10.1002/anie.200703133
|
[39]
|
Dong, M., Hovgaard, M.B., Mamdouh, W., Xu, S., Otzen, D.E. and Besenbacher, F. (2008) AFM-Based Force Spectroscopy Measurements of Mature Amyloid Fibrils of the Peptide Glucagon. Nanotechnology, 19, Article ID: 384013.
https://doi.org/10.1088/0957-4484/19/38/384013
|
[40]
|
Mostaert, A.S., Higgins, M.J., Fukuma, T., Rindi, F. and Jarvis, S.P. (2006) Nanoscale Mechanical Characterisation of Amyloid Fibrils Discovered in a Natural Adhesive. Journal of Biological Physics, 32, 393-401.
https://doi.org/10.1007/s10867-006-9023-y
|
[41]
|
Mostaert, A.S. and Jarvis, S.P. (2007) Beneficial Characteristics of Mechanically Functional Amyloid Fibrils Evolutionarily Preserved in Natural Adhesives. Nanotechnology, 18, Article ID: 044010. https://doi.org/10.1088/0957-4484/18/4/044010
|
[42]
|
Fukuma, T., Mostaert, A.S. and Jarvis, S.P. (2006) Explanation for the Mechanical Strength of Amyloid Fibrils. Tribology Letters, 22, 233-237.
https://doi.org/10.1007/s11249-006-9086-8
|
[43]
|
Kalinin, S.V., Rodriguez, B.J., Jesse, S., Seal, K., Proksch, R., Hohlbauch, S., Revenko, I., Thompson, G.L. and Vertegel, A.A. (2007) Towards Local Electromechanical Probing of Cellular and Biomolecular Systems in a Liquid Environment. Nanotechnology, 18, Article ID: 424020. https://doi.org/10.1088/0957-4484/18/42/424020
|
[44]
|
Gazit, E. (2002) The “Correctly Folded” State of Proteins: Is It a Metastable State? Angewandte Chemie International Edition, 18, 257-259.
https://doi.org/10.1002/1521-3773(20020118)41:2<257::AID-ANIE257>3.0.CO;2-M
|
[45]
|
Kirshenbaum, K. and Daggett, V. (1995) PH-Dependent Conformations of the Amyloid β(1-28) Peptide Fragment Explored Using Molecular Dynamics. Biochemistry, 34, 7629-7639. https://doi.org/10.1021/bi00023a009
|
[46]
|
Urbanc, B., Cruz, L., Ding, F., Sammond, D., Khare, S., Buldyrev, S.V., Stanley, H.E. and Dokholyan, N.V. (2004) Molecular Dynamics Simulation of Amyloid b Dimer Formation. Biophysical Journal, 87, 2310-2321.
https://doi.org/10.1529/biophysj.104.040980
|
[47]
|
Buchete, N., Tycko, R. and Hummer, G. (2005) Molecular Dynamics Simulations of Alzheimer’s β-Amyloid Protofilaments. Journal of Molecular Biology, 353, 804-821.
https://doi.org/10.1016/j.jmb.2005.08.066
|
[48]
|
Strodel, B. (2021) Amyloid Aggregation Simulations: Challenges, Advances and Perspectives. Current Opinion in Structural Biology, 67, 145-152.
https://doi.org/10.1016/j.sbi.2020.10.019
|
[49]
|
Kelly, C.M., Northey, T., Ryan, K., Brooks, B.R., Kholkin, A.L., Rodriguez, B.J. and Buchete, N. (2015) Conformational Dynamics and Aggregation Behavior of Piezoelectric Diphenylalanine Peptides in an External Electric Field. Biophysical Chemistry, 196, 16-24. https://doi.org/10.1016/j.bpc.2014.08.009
|
[50]
|
Lee, C. and Ham, S. (2011) Characterizing Amyloid-Beta Protein Misfolding from Molecular Dynamics Simulations with Explicit Water. Journal of Computational Chemistry, 32, 349-355. https://doi.org/10.1002/jcc.21628
|
[51]
|
Narayan, B., Herbert, C., Rodriguez, B.J., Brooks, B.R. and Buchete, N.-V. (2021) Replica Exchange Molecular Dynamics of Diphenylalanine Amyloid Peptides in Electric Fields. The Journal of Physical Chemistry B, 125, 5233-5242.
https://doi.org/10.1021/acs.jpcb.1c01939
|
[52]
|
Morel, B., Varela, L., Azuaga, A.I. and Conejero-Lara, F. (2010) Environmental Conditions Affect the Kinetics of Nucleation of Amyloid Fibrils and Determine Their Morphology. Biophysical Journal, 99, 3801-3810.
https://doi.org/10.1016/j.bpj.2010.10.039
|
[53]
|
Niu, L., Liu, L., Xi, W., Han, Q., Li, Q., Yu, Y., et al. (2016) Synergistic Inhibitory Effect of Peptide-Organic Coassemblies on Amyloid Aggregation. ACS Nano, 10, 4143-4153. https://doi.org/10.1021/acsnano.5b07396
|
[54]
|
Yu, L., Yang, Y. and Wang, C. (2019) Peptide Self-Assembly and Its Modulation: Imaging on the Nanoscale. In: Perrett, S., Buell, A. and Knowles, T., Eds., Biological and Bio-Inspired Nanomaterials. Advances in Experimental Medicine and Biology, Vol. 1174, Springer, Singapore, 35-60. https://doi.org/10.1007/978-981-13-9791-2_2
|
[55]
|
Chrobak, W., Pacut, D.W., Blomgren, F., Rodin, A., Swenson, J. and Ermilova, I. (2021) Component of Cannabis, Cannabidiol, as a Possible Drug against the Cytotoxicity of Aβ(31-35) and Aβ(25-35) Peptides: An Investigation by Molecular Dynamics and Well-Tempered Metadynamics Simulations. ACS Chemical Neuroscience, 12, 660-674. https://doi.org/10.1021/acschemneuro.0c00692
|
[56]
|
Cohen, T., Frydman-Marom, A., Rechter, M. and Gazit, E. (2006) Inhibition of Amyloid Fibril Formation and Cytotoxicity by Hydroxyindole Derivatives. Biochemistry, 45, 4727-4735. https://doi.org/10.1021/bi051525c
|
[57]
|
Porat, Y., Abramowitz, A. and Gazit, E. (2006) Inhibition of Amyloid Fibril Formation by Polyphenols: Structural Similarity and Aromatic Interactions as a Common Inhibition Mechanism. Chemical Biology and Drug Design, 67, 27-37.
https://doi.org/10.1111/j.1747-0285.2005.00318.x
|
[58]
|
Yang, A., Li, X., Li, D., Zhang, M., Du, H., Li, C., et al. (2012) Observation of Molecular Inhibition and Binding Structures of Amyloid Peptides. Nanoscale, 4, 1895-1909.
https://doi.org/10.1039/c2nr11508e
|
[59]
|
Huang, Q., Zhao, Q., Peng, J., Yu, Y., Wang, C., et al. (2019) Peptide-Polyphenol (KLVFF/EGCG) Binary Modulators for Inhibiting Aggregation and Neurotoxicity of Amyloid-β Peptide. ACS Omega, 4, 4233-4242.
https://doi.org/10.1021/acsomega.8b02797
|
[60]
|
Pillai, V., Tych, K.M., Rubini, M., Rodriguez, B. and Benedetto, A. (2019) Room-Temperature Ionic Liquids in Protein Amyloidogenesis: A Combined Neutron Scattering, Atomic Force Microscopy and Optical Tweezer Study. European Biophysics Journal with Biophysics Letters, 48, S216-S216.
|
[61]
|
Mahmoudi, M., Akhavan, O., Ghavami, M., Rezaee, F. and Ghiasi, S.M.A. (2012) Graphene Oxide Strongly Inhibits Amyloid Beta Fibrillation. Nanoscale, 4, 7322-7325.
https://doi.org/10.1039/c2nr31657a
|
[62]
|
Wang, J., Cao, Y., Li, Q., Liu, L. and Dong, M. (2015) Size Effect of Graphene Oxide on Modulating Amyloid Peptide Assembly. Chemistry—A European Journal, 21, 9632-9637. https://doi.org/10.1002/chem.201500577
|
[63]
|
Wang, X., Han, Q., Liu, X., Wang, C. and Yang, R. (2019) Multifunctional Inhibitors of β-Amyloid Aggregation Based on MoS2/AuNR Nanocomposites with High near-Infrared Absorption. Nanoscale, 11, 9185-9193.
https://doi.org/10.1039/C9NR01845J
|
[64]
|
Yousaf, M., Huang, H., Li, P., Wang, C. and Yang, Y. (2017) Fluorine Functionalized Graphene Quantum Dots as Inhibitor against HIAPP Amyloid Aggregation. ACS Chemical Neuroscience, 8, 1368-1377.
https://doi.org/10.1021/acschemneuro.7b00015
|
[65]
|
Han, Q., Cai, S., Yang, L., Wang, X., Qi, C., Yang, R. and Wang, C. (2017) Molybdenum Disulfide Nanoparticles as Multifunctional Inhibitors against Alzheimer’s Disease. ACS Applied Materials and Interfaces, 9, 21116-21123.
https://doi.org/10.1021/acsami.7b03816
|
[66]
|
Jin, Y., Sun, Y., Chen, Y., Lei, J. and Wei, G. (2019) Molecular Dynamics Simulations Reveal the Mechanism of Graphene Oxide Nanosheet Inhibition of Aβ1-42 Peptide Aggregation. Physical Chemistry Chemical Physics, 21, 10981-10991.
https://doi.org/10.1039/C9CP01803D
|
[67]
|
Ryan, K., Neumayer, S.M., Maraka, H.V.R., Kholkin, A.L., Rice, J.H. and Rodriguez, B.J. (2017) Thermal and Aqueous Stability Improvement of Graphene Oxide Enhanced Diphenylalanine Nanocomposites. Science and Technology of Advanced Materials, 18, 172-179. https://doi.org/10.1080/14686996.2016.1277504
|
[68]
|
Almohammed, S., Zhang, F., Rodriguez, B.J. and Rice, J.H. (2019) Electric Field-Induced Chemical Surface-Enhanced Raman Spectroscopy Enhancement from Aligned Peptide Nanotube-Graphene Oxide Templates for Universal Trace Detection of Biomolecules. The Journal of Physical Chemistry Letters, 10, 1878-1887.
https://doi.org/10.1021/acs.jpclett.9b00436
|
[69]
|
Salahuddin, P., Khan, R. H., Furkan, M., Uversky, V.N., Islam, Z. and Fatima, M.T. (2021) Mechanisms of Amyloid Proteins Aggregation and Their Inhibition by Antibodies, Small Molecule Inhibitors, Nano-Particles and Nano-Bodies. International Journal of Biological Macromolecules, 186, 580-590.
https://doi.org/10.1016/j.ijbiomac.2021.07.056
|
[70]
|
Hu, N.-W., Nicoll, A.J., Zhang, D., Mably, A.J., O’Malley, T., Purro, S.A., et al. (2014) MGlu5 Receptors and Cellular Prion Protein Mediate Amyloid-β-Facilitated Synaptic Long-Term Depression in Vivo. Nature Communications, 5, 3374.
https://doi.org/10.1038/ncomms4374
|
[71]
|
Zhang, D., Mably, A.J., Walsh, D.M. and Rowan, M.J. (2017) Peripheral Interventions Enhancing Brain Glutamate Homeostasis Relieve Amyloid β- and TNFα-Mediated Synaptic Plasticity Disruption in the Rat Hippocampus. Cerebral Cortex, 27, 3724-3735.
https://doi.org/10.1093/cercor/bhw193
|
[72]
|
Sarell, C.J., Quarterman, E., Yip, D.C.-M., Terry, C., Nicoll, A.J., Wadsworth, J.D. F.,et al. (2017) Soluble Aβ Aggregates Can Inhibit Prion Propagation. Open Biology, 7, Article ID: 170158. https://doi.org/10.1098/rsob.170158
|
[73]
|
Ondrejcak, T., Hu, N.-W., Qi, Y., Klyubin, I., Corbett, G.T., et al. (2019) Soluble Tau Aggregates Inhibit Synaptic Long-Term Depression and Amyloid β-Facilitated LTD in Vivo. Neurobiology of Disease, 127, 582-590.
https://doi.org/10.1016/j.nbd.2019.03.022
|
[74]
|
Stine, W.B., Jungbauer, L., Yu, C. and LaDu, M.J. (2010) Preparing Synthetic Aβ in Different Aggregation States. In: Roberson, E., Ed., Alzheimer’s Disease and Frontotemporal Dementia, Methods in Molecular Biology, Vol. 670, Humana Press, Totowa, 13-32. https://doi.org/10.1007/978-1-60761-744-0_2
|
[75]
|
Yang, D.-S., Yip, C.M., Huang, T.H.J., Chakrabartty, A. and Fraser, P.E. (1999) Manipulating the Amyloid-β Aggregation Pathway with Chemical Chaperones. Journal of Biological Chemistry, 274, 32970-32974. https://doi.org/10.1074/jbc.274.46.32970
|
[76]
|
Kozela, E., Juknat, A. and Vogel, Z. (2017) Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid. International Journal of Molecular Sciences, 18, 1-20. https://doi.org/10.3390/ijms18081669
|
[77]
|
Stankovic, I.M., Niu, S., Hall, M.B. and Zaric, S.D. (2020) Role of Aromatic Amino Acids in Amyloid Self-Assembly. International Journal of Biological Macromolecules, 156, 949-959. https://doi.org/10.1016/j.ijbiomac.2020.03.064
|
[78]
|
Poli, G., Ponti, W., Carcassola, G., Ceciliani, F., Colombo, L., Dall’Ara, P., et al. (2003) In Vitro Evaluation of the Anti-Prionic Activity of Newly Synthesized Congo Red Derivatives. Arzneimittel-Forschung/Drug Research, 53, 875-888.
https://doi.org/10.1055/s-0031-1299845
|
[79]
|
Lorenzo, A. and Yankner, B.A. (1994) Beta-Amyloid Neurotoxicity Requires Fibril Formation and Is Inhibited by Congo Red. Proceedings of the National Academy of Sciences of the United States of America, 91, 12243-12247.
https://doi.org/10.1073/pnas.91.25.12243
|
[80]
|
Lee, V.M.Y. (2002) Amyloid Binding Ligands as Alzheimer’s Disease Therapies. Neurobiology of Aging, 23, 1039-1042.
https://doi.org/10.1016/S0197-4580(02)00121-5
|
[81]
|
Conte, A., Pellegrini, S. and Tagliazucchi, D. (2003) Synergistic Protection of PC12 Cells from β-Amyloid Toxicity by Resveratrol and Catechin. Brain Research Bulletin, 62, 29-38. https://doi.org/10.1016/j.brainresbull.2003.08.001
|
[82]
|
Scherzer-Attali, R., Pellarin, R., Convertino, M., Frydman-Marom, A., Egoz-Matia, N., Peled, S., et al. (2010) Complete Phenotypic Recovery of an Alzheimer’s Disease Model by a Quinone-Tryptophan Hybrid Aggregation Inhibitor. PLOS ONE, 5, e11101. https://doi.org/10.1371/journal.pone.0011101
|
[83]
|
Cukalevski, R., Boland, B., Frohm, B., Thulin, E., Walsh, D. and Linse, S. (2012) Role of Aromatic Side Chains in Amyloid β-Protein Aggregation. ACS Chemical Neuroscience, 3, 1008-1016. https://doi.org/10.1021/cn300073s
|
[84]
|
Lashuel, H.A., Hartley, D.M., Balakhaneh, D., Aggarwal, A., Teichberg, S. and Callaway, D.J.E. (2002) New Class of Inhibitors of Amyloid-β Fibril Formation: Implications for the Mechanism of Pathogenesis in Alzheimer’s Disease. Journal of Biological Chemistry, 277, 42881-42890. https://doi.org/10.1074/jbc.M206593200
|
[85]
|
Heller, G.T., Aprile, F.A., Michaels, T.C.T., Limbocker, R., Perni, M., Ruggeri, F.S., et al. (2020) Small-Molecule Sequestration of Amyloid-β as a Drug Discovery Strategy for Alzheimer’s Disease. Science Advances, 6, eabb5924.
https://doi.org/10.1126/sciadv.abb5924
|